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Objectives: The pH of cardioplegic solutions is postulated to affect myocar- 
dial protection during neonatal hypothermic irculatory arrest. Neither 
optimization of cardioplegic pH nor its influence on intracellular pH 
during hypothermic circulatory arrest has been previously studied in vivo. 
Thus we examined the effects of the pH of cardioplegic solutions on 
postischemic ardiac function in vivo, including two possible operative 
mechanisms: (1) reduction in adenosine triphosphate use and depletion of 
high-energy phosphate stores or (2) reduction of H ÷ flux during reperfu- 
sion, or both. Methods: Dynamic 31p spectroscopy was used to measure rates 
of adenosine triphosphate use, high-energy phosphate depletion, cytosolic 
acidification during hypothermic circulatory arrest, and phosphocreatine 
repletion and realkalinization during reperfusion. Neonatal pigs in three 
groups (n = 8 each)--group A, acidic cardioplegia (pH = 6.8); group B, 
basic cardioplegia (pH = 7.8); and group N, no cardioplegia--underwent 
hypothermia at 20 ° C with 60 minutes of hypothermic cardioplegia followed 
by reperfusion. Results: Recoveries of peak elastance, stroke work, and 
diastolic stiffness were superior in group B. Indices of ischemic adenosine 
triphosphate use, initial phosphocreatine d pletion rate, and % the expo- 
nential decay half-time, were not different among groups. Peak [H ÷] in 
group A (end-ischemia) was significantly elevated over that of group B. The 
realkalinization rate was reduced in group B compared with that in groups 
A (p = 0.015) and N (p = 0.035), with no difference between groups A and 
N (p = 0.3). Cytosolic realkalinization rate was markedly reduced and the 
half-time of [H +] decay was increased during reperfusion in group B. 
Conclusions: Superior postischemic ardiac function in group B is not 
related to alterations in ischemic adenosine triphosphate use or high- 
energy store depletion, but may be due to slowing in H + eiflux during 
reperfusion, which should reduce Ca ÷÷ and Na ÷ influx. (J Thorac Cardio- 
vasc Surg 1997;114:601-8) 
H ypothermia provides the principal mode of myo- 
cardial protection during cardiac operations in 
the neonate. Although cardioplegia serves an ad- 
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junctive role, optimization of the pH of cardioplegic 
solutions is a source of considerable controversy. 
Experimental support for clinical recommendations 
promoting an alkaline cardioplegia strategy is diffi- 
cult to trace. 1 Data obtained from several models 
have suggested that an acidic cardioplegia strategy 
may provide superior postischemic function. 24 Un- 
fortunately, these studies were performed under 
various technical imitations and have not defined 
the mechanisms through which this putative superi- 
ority is provided. It has been suggested that acidic 
cardioplegia pH effectively lowers intracellular pH, 
thereby reducing cellular metabolic needs and aden- 
osine triphosphate (ATP) use. 2 Surprisingly, metic- 
ulous myocardial intracellular pH measurements 
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have not been performed uring comparisons of the 
pH of cardioplegic solutions in normothermic or 
hypothermic models of circulatory arrest in an at- 
tempt to prove these hypotheses. Furthermore, the 
roles of hydrogen ion (H ÷) flux and transmembrane 
proton gradients have been relatively ignored during 
experiments dealing with cardioplegia. Conceivably, 
cardioplegia influences both extracellular and intra- 
cellular pH, thus affecting this transsarcolemmal 
gradient and H + flux. Accordingly, H ÷ fluxes could 
directly and indirectly affect Na ÷ and Ca +÷ fluxes, 
which are well linked to myocardial damage. 6 
The objective of this study was to examine the 
effect of the pH of cardioplegic solutions during 
hypothermic irculatory arrest and reperfusion on 
H + flux and postischemic function in a neonatal 
model in vivo. Cardioplegic solutions with pH at 6.8 
and 7.8 were chosen for study because previous 
investigators have implied that myocardial protec- 
tion can be affected by pH changes within this 
range. 4 Additionally, we examined a control group 
without cardioplegia to determine whether car- 
dioplegic solution provides an additive effect to 
hypothermia with respect o the parameters of in- 
terest. Dynamic, highly time-resolved 31p-nuclear 
magnetic resonance (NMR) spectroscopy, the prin- 
cipal investigative method in these studies, was 
applied to define cellular acidification and realkalin- 
ization rates in a clinically relevant model. Findings 
in these experiments support raditional alkaline pH 
strategies as providing superior postischemic func- 
tion and demonstrate the operative mechanisms, 
which include a reduction in the realkalinization 
rate during reperfusion. 
Methods 
Cardiopulmonary bypass and surgical procedures. An- 
imals used in this study were handled in accordance with 
institutional nd National Institutes of Health animal care 
and use guidelines. Neonatal pigs (aged 24 to 31 days; 
weight 10 to 15 kg) were sedated with intramuscular 
injection of ketamine 10 mg/kg, atropine 0.05 mg/kg, and 
xylazine 0.2 to 0.4 mg/kg), intubated, ventilated with room 
air and oxygen, and given an intravenous dose of a- 
chloralose (40 mg/kg). The aorta and the right atrial 
appendage were cannulated and cardiopulmonary b pass 
was instituted with the use of a circuit equipped with a 
membrane oxygenator (Minimax, Medtronic, Minneapo- 
lis, Minn.) and pediatric reservoir bag. Dcxtran 40 (500 
ml) was used to prime the cardiopulmonary b pass circuit. 
A snare was placed around the ascending aorta distal to 
the aortic valve. A catheter was placed through the right 
carotid artery with the tip just proximal to the aortic snare 
for instillation of cardioplegic solution. A catheter tipped 
with a highly compliant and inflatable latex balloon was 
inserted into the ventricular chamber via a small incision 
in the left ventricular apex. A 2 cm flexible radiofrequency 
coil was sutured to the lateral wall of the left ventricle. 
Cardiac function. Pressure-volume curves were con- 
structed by recording the pressure within the intraventric- 
ular balloon as the balloon was sequentially inflated from 
a zero volume in 1 ml increments from 1 ml to 10 ml. The 
atria were paced at 150 beats/min and afterload kept 
constant by maintaining mean aortic pressure between 50 
and 60 mm Hg through the bypass pump. Peak elastance 
and diastolic stiffness were determined from the respec- 
tive slopes of the peak systolic and end-diastolic pressure 
curves. Recruitable stroke work was calculated as the area 
of the constructed pressure volume curve. 
NMR measurements. After transfer of the pig into the 
magnet, the surface coil was tuned to 81 MHz and 
matched to 50 ohms. NMR data were collected with the 
use of a General Electric spectrometer (General Electric 
Company, Fairfield, Conn.) operating at 4.7 tesla. Shim- 
ming was performed with the use of the 1H free induction 
decay at 200 MHz. 31p spectra were obtained by means of 
a cardiac gating sequence. Fully relaxed spectra were first 
obtained with the use of an approximate 16-second inter- 
pulse delay. Pulse width in a one-pulse sequence was then 
optimized according to the phosphocreatine and inorganic 
phosphate signal with the use of a 0.5- to 0.6-second 
interpulse delay. Spectra were then collected in 16-second 
blocks. This interpulse delay with 30 to 40 acquisitions per 
block served to increase overall signal intensity, but 
especially enhanced intracellular inorganic phosphate 
peak intensity. Relaxed spectra served as the reference for 
relative peak area calculations performed with the least 
squares analysis program. 7 Intracellular pH was deter- 
mined from the chemical shift difference inorganic phos- 
phate-phosphocreatine using calibration curves for intra- 
cellular pH versus chemical shift at 37 ° and 20 ° C adapted 
from Swain and associates, s As a rapid transient change in 
cardiac temperature can affect intracellular pH measure- 
ment by NMR, cardioplegic solution was instilled at the 
temperature of the heart (20 ° C). 
Protocol. Pressure-volume curves were constructed be- 
fore shimming and recording of baseline NMR data at 
370 C. Central cooling was initiated via the bypass circuit 
and completed to 20°C within 20 minutes. Baseline 
spectra were obtained, followed by rapid asanguination 
into the bypass circuit. Three experimental groups (n = 8 
in each) were used: group N, no cardioplegia; group A, 
acidic cardioplegia; nd group B. basic cardioplegia. The 
aortic snare was immediately tightened and a 20 ml/kg 
dose of cardioplegic solution was infused into the aortic 
root in groups A and B. The cardioplegic solution (20 ° C) 
consisted of an electrolyte solution (Plasma-Lyte A) with 
added potassium chloride so that the composition (in 
milliequivalents per liter) was Na* 140, K * 45. Mg- -  3, 
CI- 104, acetate 27. and gluconate 23 and was adjusted to 
pH 6.8 for group A and to 7.8 with sodium bicarbonate for 
group B. These pH values were temperature corrected to 
370 C. The insulated bore of the magnet maintained 
temperature at 20 ° C. Circuiatory arrest for 60 minutes 
was followed by reperfusiou at 20°C for 20 minutes, 
rewarming for 20 minutes to 37 ° C. and functional analy- 
ses were repeated. All temperatures were confirmed with 
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Fig. 1. Functional parameters for each experimental group are shown: ACID, acidic cardioplegia; BASE, 
basic cardioplegia; NONE, no cardioplegia. Units of measurement forpeak elastance and diastolic stiffness 
are mm Hg. m1-1 and for stroke work mm Hg. ml. *Significant differences versus group B. There are no 
significant differences between groups A and N (see text). Data are reported as means _+ standard 
deviations. 
an esophageal temperature probe positioned behind the 
heart both within and without he magnet. 
Statistical analyses. Data were evaluated with re- 
peated-measures analysis of variance within groups and 
single-factor analysis of variance across groups. When signif- 
icant F values were obtained, Scheffe's test was used to 
distinguish which groups differed significantly from one 
another. Phosphocreatine and ATP data are reported as 
relative to baseline peak areas. Rapid alterations in concen- 
trations of these high-energy phosphates and intracellular 
H + during ischemia nd reperfusion have been shown to 
follow exponential patterns. 9-n The initial ascending or 
descending portions of these exponential curves have been 
demonstrated to approximate linear functions, and their 
slopes are regarded as reaction rates. Analyses of specific 
rates are detailed in the Results ection. Linear regression 
analyses and exponential fitting of these serially acquired 
NMR data were performed with the use of the commercial 
curve analysis package provided with Axum 4.0 (Trimetrix 
Inc., Seattle, Wash.). All descriptive data in the Results 
section are reported as means +- standard eviation. A p 
value < 0.05 was considered significant. 
Results 
Cardiac function. Baseline and recovery func- 
tional parameters are illustrated in Fig. 1 for the 
three groups. Postischemic conditions were identical 
to preischemic onditions with respect to paced 
heart rate and aortic pressure maintained by the 
flow pump. Compared with preischemic values, all 
groups showed changes in nearly all functional 
parameters after reperfusion (p = 0.01). The excep- 
tion was diastolic stiffness, which increased after 
reperfusion in both the no-cardioplegia and acidic 
cardioplegia groups, but did not change significantly 
in the basic cardioplegia group (p --- 0.2). No 
significant differences were noted between the acidic 
and no-cardioplegia groups for the three measured 
parameters. Recovery peak elastance and re- 
cruitable stroke work were better in the basic car- 
dioplegia group (p = 0.03) than in either the acidic 
or no-cardioplegia groups. Postischemic diastolic 
stiffness, an index inversely related to diastolic func- 
tion, was greater in the acidic group than in the basic 
cardioplegia group (p = 0.01), but no significant 
difference was observed between the basic and 
no-cardioplegia groups (p = 0.25). 
Intraeellular pH. Consistent with other studies, 
cooling from 37 ° to 20 ° C was accompanied by an 
increase in intracellular pH in all groups & 9: in group 
A from 7.27 _+ 0.11 to 7.60 + 0.14; in group B from 
7.25 _+ 0.14 to 7.66 _+ 0.14; and in group N from 
7.26 _+ 0.14 to 7.66 _+ 0.11. Representative spectra 
are shown in Fig. 2. Fig. 3 demonstrates the typical 
course of [H +] during the ischemia protocol and 
emphasizes the differences in the speeds of acidifi- 
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Fig. 2. 31p-NMR spectra fl'om an individual experiment 
during ischemia and reperfusion. Spectra represent 16 
seconds of acquisition (0.5-second interpulse delay) with 
5000 Hz sweep width, operative frequency 81 MHz. 
Processing includes 8 Hz line broadening. Time course in 
experiment is noted at right (R indicates reperfusion). 
Stippled lines represent initial phosphocreatine assignment 
at 0 ppm and inorganic phosphate at 5.3 ppm. Note that 
inorganic phosphate peak increases in intensity and shifts 
up field (more positive) with respect to phosphocreatine 
during ischemia nd shifts down field with reperfusion. 
cation and realkalinization. We 9 have previously 
reported an initial period of slight cellular alkalin- 
ization during circulatory arrest in sheep myocar- 
dium, in which the intracellular phosphate signal is 
greater than in the pig. The signal to noise in the 
present experiments precludes detection of this pe- 
riod, which is due to proton consumption in the 
forward creatine kinase reaction. Fig. 3 demon- 
strates that no increase in [H ÷] is observable during 
the initial 10 minutes of ischemia. Data were ex- 
tracted to perform statistical analyses and define 
cellular H + flux: baseline, the average of four data 
blocks preceding circulatory arrest; peak [H÷], the 
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Fig. 3. Cytosolic H + and phosphocreatine (PCr) changes 
during a 60-minute ischemia and recovery at 20°C are 
shown for an individual experiment. Ischemia begins at 0 
minutes and reperfusion at 60 minutes. The slope of the 
solid line H + plot represents he linear realkalinization 
rate. ~i~, the decay half-time, can be calculated by fitting 
an exponential curve to the reperfusion data. The curvi- 
linear line results from such exponential fitting of phos- 
phocreatine data; ~¥cr, equals 9.6 minutes in this partic- 
ular experiment. The slope of the stippled lines represents 
the initial phosphocreatine d pletion, which reflects the 
ATP use rate during ischemia. 
and recovery [H+], the average of four data blocks 
at the end of 20 minutes of reperfusion (Fig. 4). To 
refer to H ÷ flux rates, baseline, peak, and recovery 
[H ÷] are noted in picomoles (M- 10 -9) in Figs. 3 to 
5. Baseline values are nearly identical among the 
three groups, as are the recovery values. Peak [H ÷] 
in the acidic cardioplegia hearts (end-ischemia) is
significantly elevated over that of the basic cardio- 
plegia group (p = 0.03). The differences between 
acidic cardioplegia nd no cardioplegia (p = 0.15) 
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Fig. 4. H + concentration for each group is shown at different points in the protocol. Baseline isjust before 
ischemia, peak is just before reperfusion, and recovery is20 minutes after reperfusion (all at 20 ° C). Data 
are reported as means +- standard eviations. 
and between basic cardioplegia nd no cardioplegia 
(p = 0.28) do not reach significance. Traditional 
NMR studies, which use 2- to 4-minute data block 
averages, would not define the time course of real- 
kalinization, 1° which follows an exponential pat- 
tern. Ix It is clear from the representative time course 
illustrated in Fig. 3 that the majority of H ÷ move- 
ment occurs within the first 2 to 3 minutes of 
recovery. [H ÷] decay follows an exponential course. 
The rapid rate of the initial decline can be defined 
by the slope of the line derived from linear regres- 
sion analysis by use of points from the first 2 minutes 
of recovery expressed as picomoles per minute. 
Range of the correlation coefficient squared (R 2) for 
individual experiments was 0.81 to 0.89. The entire 
course of recovery can be defined by exponential 
curve analysis to determine rn, the half-time of 
decay. The calculated initial realkalinization rates 
and r values are shown in Fig. 5. The realkaliniza- 
tion rate is lower in group B than in groups A (p = 
0.015) and N (p = 0.035), with no difference be- 
tween groups A and N (p = 0.3). Similarly, ri~ is 
significantly shorter in the acidic cardioplegia hearts 
(p = 0.03 vs B and p = 0.04 vs N), although the 
difference between groups B and N does not reach 
significance (p = 0.2). In summation, the H + flux 
data reveal that the H ÷ extrusion is slower in hearts 
that have received basic cardioplegia, although the 
eventual [H +] attained is similar among the three 
groups. 
High-energy phosphates. During the entire pro- 
tocol no significant ATP change occurred in any 
group. ATP values at end-ischemia (percent base- 
line) for groups A, B, and N, respectively, were 
100 _+ 23, 95 _+ 8, and 96 _+ 8. Initial rapid 
phosphocreatine d pletion accompanies oxygen de- 
privation even under hypothermic conditions; there 
are no significant differences in these rates among 
the groups (Fig. 6), nor were there significant dif- 
ferences in r, half-time derived from the exponential 
phosphocreatine d cay through ischemia (see Fig. 
3); respective values for z (minutes) for groups A, B, 
and N were 15.9 _+ 14, 13.5 +_ 11, and 22 _+ 14. 
Phosphocreatine r pletion is rapid compared with 
depletion in all groups (Fig. 6) and is slower in 
group B hearts (p = 0.001 vs groups A and N). 
Discussion 
The influence of the pH of cardioplegic solutions 
on intracellular H + concentration and flux in vivo 
has not been previously examined. This study was 
performed in a model that emulates conditions 
present in developing myocardium undergoing hy- 
pothermic ardiopulmonary b pass and circulatory 
arrest. The functional analyses in these studies 
support he alkaline cardioplegia strategy used clin- 
ically. 1 Contrasting data purporting an acidic cardio- 
plegia strategy as beneficial have been obtained 
primarily in isolated heart preparations. Three such 
separate studies by Iannettoni, 3 Bernard, 2 Baker, 4 
6 0 6 Portman et al. 
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Fig. 5. The initial realkalinization rate (AH+/time) at reperfusion is shown in the first panel r is the 
halftime of [H +] decrease calculated from exponential curve fitting. These data together indicate that 
realkalinization is slower in BASE. *Differences versus BASE. +Differences versus ACID. 
and their respective colleagues are frequently 
quoted and seem to challenge the concept that 
alkaline cardioplegia provides superior myocardial 
protection. These studies were technically limited 
and do not directly address the conditions currently 
considered in vivo. Specifically, Iannettoni and co- 
workers 3varied buffer under normothermic condi- 
tions and did not isolate the pH of the cardioplegic 
solution. 3Bernard and coauthors 2 did vary the pH 
of the cardioplegic solution used in mature rat 
myocardium, but functional results were equivocal 
in that acidic cardioplegia produced only transient 
superiority over basic cardioplegia with respect o 
postischemic function in the working heart prepara- 
tion. Ostensibly, this group measured intracellular 
pH concurrent with ischemia nd functional analy- 
ses. 2 However, systematic error was unwittingly in- 
troduced into their intracellular pH data because 
temperature corrections for their chemical shift-pH 
calibrations were not performed. Subsequently, oth- 
ers have demonstrated that intracellular pH calcu- 
lation without temperature calibration is inaccu- 
rate.S, 12 Baker and colleagues 4 provided evidence 
that the cardioplegia pH functional response follows 
a bell-shaped curve with the apex at pH 6.8 in both 
immature and mature isolated working rabbit 
hearts. Their study offers the most compelling evi- 
dence in the isolated heart that a cardioplegic pH of 
6.8 provides better postischemic function than a pH 
of 7.8. The model used in these experiments per- 
formed at 14°C was unique owing to extremely 
prolonged ischemic periods (3 to 4 hours). As 
intracellular pH was not monitored in Baker's tudy, 
the effect of this long duration of ischemia and 
profound hypothermia on H + flux even without 
provision of cardioplegia is unknown. 
Support hat acidic cardioplegia proffers uperior 
myocardial protection in vivo has been provided by 
data obtained in only one study. Nugent and co- 
workers 5found such a beneficial effect in adult dogs 
undergoing 2 hours of cardiac arrest at 20 ° C with 
multiple-dose cardioplegia. Intracellular pH and H + 
flux were not monitored in their study, and technical 
details such as temperature of reperfusate are not 
clearly provided. Thus it is difficult to perform 
analytical comparisons with that study. Conceivably, 
the differences are due to maturational or species 
effects, although these discrepancies may also be 
caused by the prolonged ischemia in their model. 
The rapid phosphocreatine d cline has been used 
as an index of ATP use during early ischemia or 
oxygen deprivation]' 9-11 Derivation and application 
of this index has been reviewed elsewhere. 9' 11 In 
brief, inasmuch as no aerobic ATP production oc- 
curs in early ischemia, phosphocreatine d pletion 
represents otal ATP use and follows a linear course 
until lactate production provides an anaerobic ATP 
component slightly later. ATP was held constant 
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through these protocols, regardless of pH strategy, a 
result hat corresponds with data obtained by Clark 
and coworkers 13in neonatal pigs during 1 hour of 
hypothermic circulatory arrest. Retention of ATP 
levels attests to the viability of the myocardium 
during these protocols. Thus early ischemic ATP use 
and depletion of high-energy phosphate stores 
throughout ischemia re not altered by the addition 
of cardioplegia in these studies, regardless of pH 
strategy. This finding is consistent with other studies, 
which could reveal no alterations in high-energy 
phosphate stores or myocardial oxygen consumption 
induced by cardioplegia superimposed onhypother- 
mia. 14 Clark and coworkers 13were able to demon- 
strate a decrease in high-energy phosphate store 
depletion, imposed by multiple doses of extremely 
cold cardioplegic solution during hypothermic circu- 
latory arrest; however, this effect was likely induced 
by further temperature duction, rather than by the 
cardioplegic solution itself. Phosphocreatine reple- 
tion is rapid in all three experimental groups. Al- 
though, phosphocreatine repletion rate was reduced 
in the basic cardioplegia group, this parameter is
very dependent on the myocardial oxygen consump- 
tion rate in the aerobic heart. 1° Conceivably, meta- 
bolic factors other than a discrepancy in myocardial 
oxygen consumption may also cause slowing in this 
rate. Unfortunately, oxygen consumption measure- 
ments would have added to the technical complexity 
of these experiments and were not performed. Thus 
this small reduction in phosphocreatine r pletion 
rate in the alkaline cardioplegia group cannot be 
interpreted. 
Generally, two hypotheses have been posed to 
explain the protective ffect of cardioplegia during 
hypothermic circulatory arrest. The first states that 
cardioplegia lters myocardial energy metabolism 
and thus reduces ATP use and high-energy phos- 
phate store depletion during hypothermic ischemia. 
The second hypothesis states that cardioplegia f- 
fects cellular H + fluxes and thus influences damag- 
ing ionic disturbances during reperfusion. These 
effects would be modified relative to the pH of the 
cardioplegic solution. Because deficits in myocardial 
energy metabolism during ischemia in the present 
model do not appear to be responsible for the 
superior postischemic function in the alkaline car- 
dioplegia hearts, the second hypothesis requires 
consideration. Our data support he suggestion that 
cardioplegic solution administered during ischemia 
can modify reperfusion H + fluxes according to its 

















Fig. 6. Initial rates of phosphocreatine change (z.kPCr) 
are shown for ischemia nd reperfusion i  each group. 
The rate of decrease of phosphocreatine during ischemia 
is much slower than the increase during reperfusion. 
There are no significant differences in phosphocreatine 
change/time during ischemia. Phosphocreatine recovery is
slower in BASE (see text). *Differences versus BASE. 
Data reported as means + standard eviations. 
linization after ischemia consistently produce supe- 
rior postischemic function. 6'15, 16 This rate appears 
to be sensitive not only to the intracellular pH, but 
also to the transsarcolemmal proton gradient. 17 
Accordingly, reduction of extracellular pH in reper- 
fusion medium has recently been a suggested mode 
of decreasing myocardial damage after ischemia. 
Kitakaze, Weisfeldt, and Marban 6 showed that 
reperfusion with acidic medium in the isolated heart 
preserves function. Similarly, conditions leading to 
increased intracellular acidification before reperfu- 
sion exacerbate postischemic myocardial dysfunc- 
tion. is This corresponds toour experiments in which 
slightly lower intracellular pH just before reperfu- 
sion in hearts subjected to acidic cardioplegia pro- 
vides more rapid realkalinization and more severe 
cardiac dysfunction. These findings imply that rapid 
washout of the extracellular medium with highly 
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buffered and relatively alkaline medium such as 
blood activates cellular H + extrusion. The level of 
activation is presumably dependent on the intracel- 
lular H + concentration, as well as the transsar- 
colemmal proton gradient at reperfusion. 
The relationship of cellular H + efflux to Na + and 
Ca ++ influxes, which mediate reperfusion damage, is 
well established. 6' 19, 2o Thus delayed cellular realkalin- 
ization induced by acidic reperfusion is associated with 
decreased Ca ++ influx and superior postischemic 
function. 6 The Na+/H + exchanger probably represents 
at least one mechanism through which these ion fluxes 
are linked. Elevation of intracellular H + relative to 
extracellular H + promotes Na+/H + exchange across 
the sarcolemma, and this increased Na + influx stimu- 
lates cellular Ca ++ influx through Na+/Ca ++ ex- 
change.19, 21 Pharmacologic inhibition of the Na+/H + 
exchanger has been shown even under hypothermic 
conditions to decrease intracellular Na + and intracel- 
lular Ca ++ during reoxygenation after hypoxia and 
thus preserve myocardial function. 16 
In summary, these data show that a basic cardio- 
plegia strategy provides superior postischemic ar- 
diac function in a model emulating clinically rele- 
vant conditions and durations of hypothermic 
circulatory arrest. The cardioplegia strategy does 
not alter the balance between high-energy phos- 
phate production and use. The presumed mecha- 
nism for this superiority is a slightly" lower intracel- 
lular H + at end-ischemia, which effectively reduces 
H + elttux during reperfusion. Although Na + and 
Ca ++ influx could not be measured in this study, 
other investigators have shown that an H + elthix is 
closely linked to these. The data in these experi- 
ments is consistent with those of studies showing 
that a reduction in these ion fluxes during reperfu- 
sion preserves postischemic myocardial function. 
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